IL10 and breast carcinoma: Consistent with the RNA expression, protein secretion from the metformin-treated breast cancer cells also showed decreased expressions of IL-4, IL-10 and IL-13 in the medium (Supplementary Figure 2A, 2B and 2C) and an increased expression of IFN-γ (Supplementary Figure 2D).